Nikolaus B. Binder, MD PhD

CSO
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, Vienna, Austria
Vienna, Wien, Austria

Nikolaus Binder was born in 1980 in Vienna, Austria. Following his studies of medicine at the Medical University of Vienna, where he obtained his MD degree in 2005, he entered a PhD program on molecular signal transduction at the Medical University , where he obtained his PhD degree in 2009. After 3 years working abroad at the Hospital for Special Surgery in New York, USA, he joint Technoclone in 2013 as CSO. His recent work has focused on the optimization of TTP diagnostics which included a first of its kind rapid ADAMTS13 test and a fully automated solution for ADAMTS13 activity measurement and the proof of principle of a fast and fully automated FVIII functional inhibitor test and novel Lupus tests.

Presentation(s):

• PB0313 - Towards The Standardisation Of ADAMTS-13 Antibody Testing In Thrombotic Thrombocytopenic Purpura (TTP)–Results Of The IMATAS Collaborative Study

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB1119 - Evaluation of Assay Performance Measuring Plasma Concentrations of Apixaban, Edoxaban, Rivaroxaban Using a Standard Heparin Reagent on a Fully Automated Coagulation Analyser

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• OC 77.5 - Development of a Rapid and Fully Automated FVIII Inhibitor Assay Insensitive to the Presence of Emicizumab

  Wednesday, June 28, 2023
  11:15 – 11:30 ET